Tritiated digoxin. 18. Studies in infants and children

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Tritiated digoxin. 18. Studies in infants and children

Abstract

References

Digoxin metabolism in hypo- and hyperthyroidism. Studies with tritiated digoxin in thyroid disease

Tritiated digoxin XVI. Gastric absorption

Tritiated digoxin. XV. Serum protein binding in human subjects

Localization of the renal excretion of the tritiated digoxin

Tissue concentration and turnover of tritiated digoxin in dogs

Peritoneal dialysis and hemodialysis of tritiated digoxin

Tritiated digoxin studies in human subjects

STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE

STUDIES FOLLOWING INTRAMUSCULAR TRITIATED DIGOXIN IN HUMAN SUBJECTS

Citations

Distribution and elimination of digoxin in infants

Absorption of digoxin in infants

Single daily dose of digoxin for maintenance therapy of infants and children with cardiac disease: is it reliable?

Digoxin therapy in low-birth-weight infants with patent ductus arteriosus

Digoxin levels in neonates

Digitalis (third of four parts)

Letter: "Digitalis cachexia"

Infant versus adult plasma digoxin levels

Serum levels and renal excretion of digoxin during maintenance therapy in children

Post-mortem distribution and tissue concentrations of digoxin in infants and adults

Plasma digoxin concentrations and urinary excretion during a 'simpler' regimen of infant digitalization

Serum digoxin concentration and half-life in newborn

Current considerations in digoxin usage

Clinical pharmacology of digitalis glycosides: a developmental viewpoint

Digitalis glycosides: mechanisms and manifestations of toxicity. Part III

Serum digitalis measurements in the assessment of digitalis resistance and sensitivity

Digitalis glycosides: mechanisms and manifestations of toxicity. Part II

Digitalis glycosides: mechanisms and manifestations of toxicity. Part I

Drug therapy of heart disease in pediatric patients. II. The treatment of congestive heart failure in infants and children with digitalis preparations

Paradoxical behavior of serum digoxin concentrations in an anuric neonate

Once-daily versus twice-daily dosing of digoxin in the pediatric age group

Dosage of digoxin in premature infants

Current concepts of therapy with digitalis glycosides. 1

The pharmacokinetics of digoxin in newborn and adult sheep

Population analysis for the optimization of digoxin treatment in Japanese paediatric patients

Plasma digoxin concentration in different age groups (author's transl)

Related Concepts

Related Feeds

Cardiology Journals

Birth Defects

Related Papers

Serum levels of digoxin in infants and children

Plasma digoxin levels in infants

Serum digoxin concentrations in the human fetus, neonate and infant

Effects of intravenous infusion of ouabain on respiration

Digoxin